Carbapenem-Resistant Enterobacteriaceae — MCQs
All are true about ESBL except -
Which of the following is NOT a mechanism of antibiotic resistance?
Carbapenem which has a tendency to cause maximum seizures?
All the following statements are true regarding beta-lactams except:
Burkholderia cepacia is resistant to which of the following antibiotics?
The ELISA test for virulence antigen is used to diagnose which type of Escherichia coli?
The bacterial drug resistance in tuberculosis results from which mechanism?
How does Staphylococcus aureus become resistant to methicillin?
Which of the following is NOT a mechanism of resistance to MRSA?
Hain test is used for:
Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Practice Questions and MCQs
Question 1: All are true about ESBL except -
- A. Resistant to carbapenems (Correct Answer)
- B. Classification is based on 3rd generation cephalosporin sensitivity
- C. Cephalosporin sensitivity testing is required to confirm ESBL
- D. Ambler classification is based on molecular structure
Explanation: ***Resistant to carbapenems*** - **ESBL (Extended-Spectrum Beta-Lactamase)**-producing bacteria are typically **susceptible to carbapenems**. Carbapenems are a primary treatment option for serious ESBL infections. - Resistance to carbapenems suggests the presence of other resistance mechanisms, such as **carbapenemases**, not ESBLs. *Classification is based on 3rd generation cephalosporin sensitivity* - ESBLs are specifically defined by their ability to hydrolyze and confer resistance to **extended-spectrum cephalosporins** (e.g., ceftriaxone, ceftazidime) and aztreonam. - This characteristic resistance to third-generation cephalosporins is key to their definition and clinical identification. *Cephalosporin sensitivity testing is required to confirm ESBL* - **Phenotypic confirmatory tests** for ESBLs involve demonstrating increased resistance to an extended-spectrum cephalosporin alone compared to the same cephalosporin combined with a **beta-lactamase inhibitor** like clavulanic acid. - This testing is crucial for accurate detection and guiding appropriate antibiotic therapy. *Ambler classification is based on molecular structure* - The **Ambler classification system** categorizes beta-lactamases into classes A, B, C, and D based on their **amino acid sequence homology** and their active site mechanisms. - This classification helps in understanding the biochemical properties and substrate profiles of different beta-lactamases, including ESBLs.
Question 2: Which of the following is NOT a mechanism of antibiotic resistance?
- A. Efflux pump activity
- B. Inactivation by enzymes such as beta-lactamase
- C. Modification of drug target sites
- D. Increased drug absorption (Correct Answer)
Explanation: ***Increased drug absorption*** - **Increased drug absorption** would lead to a higher intracellular concentration of the antibiotic, making it *more potent* against the bacteria rather than contributing to resistance. - Antibiotic resistance mechanisms aim to *reduce the effective concentration* of the drug at its target site or *alter the target itself*. *Efflux pump activity* - **Efflux pumps** are bacterial membrane proteins that actively pump antibiotics out of the bacterial cell [3]. - This mechanism *reduces the intracellular concentration* of the antibiotic, preventing it from reaching its therapeutic target [3]. *Inactivation by enzymes such as beta-lactamase* - Bacteria can produce enzymes like **beta-lactamase** that *chemically modify or degrade* the antibiotic molecule, rendering it inactive [2]. - This is a common mechanism of resistance against **beta-lactam antibiotics** (e.g., penicillin, cephalosporins) [2]. *Modification of drug target sites* - Bacteria can develop mutations that *alter the structure of the antibiotic's target site*, such as a bacterial ribosome or cell wall component [1]. - This change in the target means the antibiotic can no longer bind effectively or interfere with cellular processes, thus *losing its efficacy* [1].
Question 3: Carbapenem which has a tendency to cause maximum seizures?
- A. Imipenem (Correct Answer)
- B. Ertapenem
- C. Doripenem
- D. Meropenem
Explanation: ***Imipenem*** - **Imipenem** is associated with the highest risk of **seizures** among the carbapenems, particularly in patients with **renal impairment**, pre-existing **CNS disorders**, or high doses. - Its high affinity for **GABA-A receptors** in the central nervous system is thought to contribute to its proconvulsant effects. *Ertapenem* - While all carbapenems carry some risk of seizures, **ertapenem** has a **lower incidence** compared to imipenem. - It is often favored in patients without CNS infections or severe renal dysfunction due to its once-daily dosing. *Doripenem* - **Doripenem** also has a relatively **low risk of seizures** compared to imipenem. - It is generally well-tolerated, with side effects similar to other carbapenems but at a reduced frequency for CNS events. *Meropenem* - **Meropenem** is known to have a **lower seizure potential** than imipenem, making it a preferred choice for patients with a history of seizures or those with CNS infections. - Its **reduced affinity** for GABA-A receptors contributes to its better CNS tolerability.
Question 4: All the following statements are true regarding beta-lactams except:
- A. Methicillin is not orally bioavailable and is given parenterally.
- B. Imipenem should be given with cilastatin
- C. Meropenem does not require cilastatin for protection against renal toxicity.
- D. Aztreonam shows cross-reactivity with cephalexin. (Correct Answer)
Explanation: ***Aztreonam shows cross-reactivity with cephalexin.*** - **Aztreonam** is a monobactam with a distinct chemical structure from other beta-lactams, resulting in a different **allergy profile** and lack of significant **cross-reactivity** with other beta-lactams, including cephalosporins like cephalexin. - Its unique structure also means it is specifically active against **gram-negative bacteria** and generally resistant to common beta-lactamases that deactivate other beta-lactams. *Imipenem should be given with cilastatin* - **Imipenem** is rapidly metabolized in the renal tubules by **dehydropeptidase-1**, leading to reduced antibiotic concentrations and potential for nephrotoxicity. - **Cilastatin** is a dehydropeptidase inhibitor that prevents the breakdown of imipenem, ensuring adequate drug levels and reducing renal damage. *Methicillin is not orally bioavailable and is given parenterally.* - **Methicillin** is an acid-labile penicillin, meaning it is extensively degraded by stomach acid when taken orally, leading to poor absorption. - Due to its instability in acidic environments, methicillin must be administered **parenterally (intravenously or intramuscularly)** to achieve therapeutic concentrations. *Meropenem does not require cilastatin for protection against renal toxicity.* - **Meropenem** is another carbapenem, but it is much more stable to metabolism by **renal dehydropeptidase-1** compared to imipenem. - This inherent stability eliminates the need for co-administration with **cilastatin** to prevent its degradation and protect against nephrotoxicity.
Question 5: Burkholderia cepacia is resistant to which of the following antibiotics?
- A. Trimethoprim-sulfamethoxazole
- B. Cefotetan (Correct Answer)
- C. Ceftazidime
- D. Temocillin
Explanation: ***Cefotetan*** - *Burkholderia cepacia* shows **consistent resistance** to second-generation cephalosporins and cephamycins like **cefotetan**. - This organism is intrinsically resistant to **aminoglycosides** (gentamicin, tobramycin) and **polymyxins** (colistin), and shows variable resistance to many beta-lactams. - Among the options provided, cefotetan represents the most consistently ineffective agent. *Ceftazidime* - **Ceftazidime** (third-generation cephalosporin) shows **variable susceptibility** with *B. cepacia*. - While resistance is common, it is **not uniform**, and ceftazidime is sometimes used in **combination therapy** for B. cepacia infections. - Not considered a classic example of intrinsic resistance. *Trimethoprim-sulfamethoxazole* - **TMP-SMX** is the **first-line treatment** for *Burkholderia cepacia* infections. - It demonstrates good activity and is the preferred antimicrobial agent for this organism. - Resistance can develop but is not intrinsic. *Temocillin* - **Temocillin** (carboxypenicillin) has demonstrated activity against *B. cepacia*. - Used particularly in Europe for treating infections caused by this organism. - Not an antibiotic to which *B. cepacia* shows consistent resistance.
Question 6: The ELISA test for virulence antigen is used to diagnose which type of Escherichia coli?
- A. ETEC
- B. EIEC
- C. EPEC (Correct Answer)
- D. EHEC
Explanation: ***EPEC (Enteropathogenic E. coli)*** - The **ELISA test for virulence antigen** is specifically used to detect **Bundle-Forming Pilus (BFP)** and **EAF (E. coli adherence factor) plasmid antigens** in EPEC - EPEC is a major cause of **infantile diarrhea** in developing countries - The virulence antigen detection by ELISA is a **standard diagnostic method** for identifying typical EPEC strains - EPEC demonstrates **localized adherence** pattern on HEp-2 cells and possesses the **LEE (locus of enterocyte effacement) pathogenicity island** *ETEC (Enterotoxigenic E. coli)* - ETEC causes **traveler's diarrhea** by producing **heat-labile (LT)** and **heat-stable (ST) enterotoxins** - Diagnosis involves detecting these **specific toxins or their genes** using PCR or toxin-specific immunoassays - ELISA for virulence antigens is not the primary diagnostic method for ETEC *EIEC (Enteroinvasive E. coli)* - EIEC invades intestinal epithelial cells, causing **dysentery-like illness** similar to *Shigella* - Diagnosis relies on detecting **invasion plasmid antigen H (IpaH)** or demonstrating **invasive properties** in cell culture assays - Serotyping and molecular methods are preferred over ELISA for virulence antigens *EHEC (Enterohemorrhagic E. coli)* - EHEC (particularly **O157:H7**) produces **Shiga toxins (Stx1 and Stx2)** causing hemorrhagic colitis and HUS - Diagnosis focuses on detecting **Shiga toxins** using specific ELISA or **stx genes** by PCR - Sorbitol-MacConkey agar is used for initial screening of O157:H7 strains
Question 7: The bacterial drug resistance in tuberculosis results from which mechanism?
- A. Transduction
- B. Transformation
- C. Plasmid mediated resistance
- D. Mutation (Correct Answer)
Explanation: **Explanation:** The development of drug resistance in *Mycobacterium tuberculosis* (MTB) is unique compared to many other bacteria. **Why Mutation is Correct:** In *Mycobacterium tuberculosis*, antimicrobial resistance occurs exclusively due to **spontaneous chromosomal mutations**. Unlike many Gram-negative or Gram-positive bacteria, MTB does not possess horizontal gene transfer mechanisms like plasmids or transposons. These random genetic mutations occur at a predictable frequency (e.g., 1 in $10^6$ to $10^8$ cell divisions). When a patient is treated with inadequate monotherapy or irregular dosing, these resistant mutants are "selected" and survive to multiply, leading to **acquired resistance**. **Why Incorrect Options are Wrong:** * **Transduction & Transformation (A & B):** These are forms of horizontal gene transfer involving bacteriophages and the uptake of free DNA, respectively. While common in bacteria like *Staphylococcus* or *Streptococcus*, they have no documented role in clinical drug resistance in MTB. * **Plasmid-mediated resistance (C):** Plasmids are extrachromosomal DNA elements frequently responsible for multi-drug resistance in Enterobacteriaceae (e.g., via R-plasmids). *M. tuberculosis* does not harbor resistance-carrying plasmids. **High-Yield Clinical Pearls for NEET-PG:** * **Multi-Drug Resistant TB (MDR-TB):** Defined as resistance to at least **Isoniazid (H)** and **Rifampicin (R)**. * **Genetic Targets:** * **Rifampicin resistance:** Mutation in the **rpoB** gene (beta subunit of RNA polymerase). * **Isoniazid resistance:** Mutation in **katG** (most common) or **inhA** genes. * **DOTS Strategy:** The primary reason for using "Multi-Drug Therapy" in TB is to prevent the selection of these spontaneous resistant mutants. The probability of a bacilli developing simultaneous mutations to two drugs is mathematically negligible ($10^{-6} \times 10^{-8} = 10^{-14}$).
Question 8: How does Staphylococcus aureus become resistant to methicillin?
- A. Heat shock protein
- B. Protein A
- C. Transpeptidase (Correct Answer)
- D. Protein C
Explanation: ### Explanation **1. Why Transpeptidase is Correct:** Methicillin resistance in *Staphylococcus aureus* (MRSA) is primarily mediated by the acquisition of the **mecA gene**. This gene encodes a modified **Penicillin-Binding Protein (PBP2a)**. PBPs are essentially **transpeptidases**, enzymes responsible for cross-linking the peptidoglycan layers of the bacterial cell wall. While standard PBPs are inhibited by beta-lactam antibiotics (like methicillin or oxacillin), the modified transpeptidase (PBP2a) has a **low affinity** for these drugs. This allows the bacteria to continue cell wall synthesis even in the presence of the antibiotic, leading to resistance. **2. Why Other Options are Incorrect:** * **Option A (Heat shock protein):** These are molecular chaperones that help in protein folding and stress response; they do not mediate antibiotic resistance in Staphylococci. * **Option B (Protein A):** This is a key virulence factor of *S. aureus* that binds to the **Fc portion of IgG**, preventing opsonization and phagocytosis. It is not involved in drug resistance. * **Option C (Protein C):** This is a host (human) anticoagulant protein that inactivates Factors Va and VIIIa. It has no role in bacterial physiology. **3. High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Test:** The detection of the **mecA gene** by PCR is the gold standard for identifying MRSA. * **Phenotypic Screening:** Cefoxitin disk diffusion is preferred over methicillin/oxacillin disks for screening MRSA in labs because it is a better inducer of the mecA gene. * **Drug of Choice:** **Vancomycin** is the traditional drug of choice for MRSA. For VRSA (Vancomycin-resistant), Linezolid or Daptomycin are used. * **Exceptions:** MRSA is resistant to all beta-lactams **except** 5th generation cephalosporins (e.g., **Ceftaroline**).
Question 9: Which of the following is NOT a mechanism of resistance to MRSA?
- A. Resistance is chromosomally mediated.
- B. Produced mainly by alteration in PBPs.
- C. MRSA resistance is absolutely beta-lactamase dependent. (Correct Answer)
- D. Intrinsic resistance is known.
Explanation: **Explanation:** **Why Option C is the correct answer:** The hallmark of Methicillin-resistant *Staphylococcus aureus* (MRSA) is that its resistance is **independent** of beta-lactamase production. While many Staphylococci produce penicillinase (a beta-lactamase), MRSA resistance specifically arises from the acquisition of the **mecA gene**. This gene encodes an altered Penicillin-Binding Protein (**PBP2a**), which has a very low affinity for almost all beta-lactam antibiotics (penicillins, cephalosporins, and carbapenems). Therefore, even if a drug is "beta-lactamase stable" (like Methicillin or Nafcillin), it cannot bind to PBP2a, rendering the drug ineffective. **Analysis of incorrect options:** * **Option A (Chromosomally mediated):** This is a true statement. The *mecA* gene is located on a mobile genetic element called the **Staphylococcal Cassette Chromosome (SCCmec)**, which integrates into the bacterial chromosome. * **Option B (Alteration in PBPs):** This is the primary mechanism. The production of **PBP2a** instead of the normal PBPs prevents the antibiotic from inhibiting cell wall synthesis. * **Option D (Intrinsic resistance):** This is true. MRSA resistance is considered "intrinsic" because it is a structural change in the target site (PBP) that applies to the entire class of beta-lactams, regardless of the presence of enzymes. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for MRSA:** Vancomycin (Glycopeptide). * **Exception:** 5th generation cephalosporins (**Ceftaroline** and Ceftobiprole) are the only beta-lactams active against MRSA because they can bind to PBP2a. * **Detection:** Cefoxitin disk diffusion test is the preferred method in labs to detect MRSA (it is a better inducer of the *mecA* gene than methicillin). * **BORSA:** "Borderline Oxacillin-Resistant *S. aureus*" refers to strains that are resistant due to *hyper-production* of beta-lactamase, not the *mecA* gene.
Question 10: Hain test is used for:
- A. Detection of INH resistance only
- B. Detection of rifampicin resistance only
- C. Detection of both rifampicin and INH resistance (Correct Answer)
- D. Detection of resistance to all first-line anti-tuberculosis drugs
Explanation: **Explanation:** The **Hain test**, also known as the **GenoType MTBDRplus** assay, is a commercial Line Probe Assay (LPA) used for the rapid molecular detection of drug resistance in *Mycobacterium tuberculosis*. **1. Why Option C is Correct:** The Hain test utilizes PCR and reverse hybridization to identify specific mutations in the MTB genome. It simultaneously targets: * **rpoB gene:** Mutations here confer resistance to **Rifampicin**. * **katG and inhA promoter genes:** Mutations here confer resistance to **Isoniazid (INH)**. Because it detects resistance to both primary bactericidal drugs, it is the gold standard for the rapid diagnosis of Multidrug-Resistant TB (MDR-TB). **2. Why Other Options are Incorrect:** * **Options A & B:** These are incomplete. While the test does detect resistance to these drugs individually, its clinical utility lies in its ability to screen for both simultaneously to identify MDR-TB. * **Option D:** The Hain test (MTBDRplus) only covers Rifampicin and INH. Resistance to other first-line drugs (Pyrazinamide, Ethambutol) or second-line drugs (Fluoroquinolones, Aminoglycosides) requires different assays, such as the **MTBDRsl** (Second Line) test. **High-Yield Clinical Pearls for NEET-PG:** * **Turnaround Time:** Provides results within 24–48 hours, much faster than culture-based DST. * **Prerequisite:** It can be performed on smear-positive sputum samples or culture isolates. * **Key Genes to Remember:** * *rpoB* = Rifampicin * *katG* (high-level) & *inhA* (low-level) = INH. * **NTEP Protocol:** In India, LPA is a key component of the Programmatic Management of Drug-Resistant TB (PMDT).
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free